Affiliation:
1. Department of Pharmacognosy, Faculty of Pharmacy Mansoura University Mansoura Egypt
2. Department of Microbiology and Immunology, Faculty of Pharmacy Mansoura University Mansoura Egypt
Abstract
AbstractThe coronavirus disease 2019 (COVID‐19) pandemic is a worldwide war. Raising the blood pH might be a crucial strategy to chase COVID‐19. The human blood is slightly alkaline, which is essential for cell metabolism, normal physiology, and balanced immunity since all of these biological processes are pH‐dependent. Varieties of physiologic derangements occur when the blood pH is disrupted. Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) proliferates in acidic blood that magnifies the severity of COVID‐19. On the other side, blood acidemia is linked to increased morbidity and mortality because of its complications on immunity, especially in the elderly and in critical diseases such as cancer, musculoskeletal degradation, renal, cardiac, and pulmonary disorders, which result in many pathological disorders such as osteomalacia, and disturbing the hematopoiesis. Additionally, acidemia of the blood facilitates viral infection and progression. Thus, correcting the acid–base balance might be a crucial strategy for the treatment of COVID‐19, which might be attributed to the distraction of the viral spike protein to its cognate receptor angiotensin‐converting enzyme 2 and supporting the over‐taxed immunity.
Subject
Drug Discovery,Pharmaceutical Science
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献